Esperion Therapeutics, Inc. — Investor Relations & Filings
Filings indexed
871
across all filing types
Latest filing
2026-06-08
Merger & Acquisition
Country
US
United States of America
Listing
US
ESPR
Esperion Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on developing and commercializing medicines to reduce cardiovascular risk. The company specializes in once-daily, oral therapies for patients with elevated low-density lipoprotein cholesterol (LDL-C). Its portfolio is centered around adenosine triphosphate-citrate lyase (ACLY) inhibitors, a unique mechanism of action for which it brought the first treatment to market. Key products include NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe), which are approved in the U.S. and Europe. Esperion collaborates with commercial partners to facilitate global access to its medicines while its scientific team investigates new therapeutic opportunities through its pipeline.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| DEFM14A | 2026-06-08 | English | |
| 8-K | 2026-06-01 | English | |
| 10-Q - Esperion Therapeutics, Inc. (0001434868) (Filer) | 2026-05-08 | English | |
| 4 - Esperion Therapeutics, Inc. (0001434868) (Issuer) | 2026-03-18 | English | |
| 4 - Esperion Therapeutics, Inc. (0001434868) (Issuer) | 2026-03-18 | English | |
| 4 - Esperion Therapeutics, Inc. (0001434868) (Issuer) | 2026-03-18 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
12 filings
| |||||
| 47995449 | DEFM14A | 2026-06-08 | English | ||
| 47923358 | 8-K | 2026-06-01 | English | ||
| 44402054 | 10-Q - Esperion Therapeutics, Inc. (0001434868) (Filer) | 2026-05-08 | English | ||
| 32979258 | 4 - Esperion Therapeutics, Inc. (0001434868) (Issuer) | 2026-03-18 | English | ||
| 32979251 | 4 - Esperion Therapeutics, Inc. (0001434868) (Issuer) | 2026-03-18 | English | ||
| 32979254 | 4 - Esperion Therapeutics, Inc. (0001434868) (Issuer) | 2026-03-18 | English | ||
| 32966978 | 144 - Esperion Therapeutics, Inc. (0001434868) (Subject) | 2026-03-17 | English | ||
| 32966969 | 144 - Esperion Therapeutics, Inc. (0001434868) (Subject) | 2026-03-17 | English | ||
| 32966943 | 144 - Esperion Therapeutics, Inc. (0001434868) (Subject) | 2026-03-17 | English | ||
| 32891844 | 8-K - ESPERION THERAPEUTICS, INC. (0001434868) (Filer) | 2026-03-03 | English | ||
| 29771877 | 4 Filing | 2026-01-21 | English | ||
| 29771890 | 8-K Filing | 2026-01-12 | English | ||
|
2025
3 filings
| |||||
| 12218748 | FORM 4 | 2025-12-18 | English | ||
| 12218750 | FORM 4 | 2025-12-18 | English | ||
| 12218749 | FORM 4 | 2025-12-18 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Amylyx Pharmaceuticals, Inc.
Develops therapies for neurodegenerative diseases and other…
|
AMLX | US | Manufacturing |
|
AN2 Therapeutics, Inc.
Biopharmaceutical firm developing boron-based drugs for inf…
|
ANTX | US | Manufacturing |
|
Ananda Pharma Plc
Biopharmaceutical firm developing cannabinoid-based medicin…
|
ANAN | GB | Manufacturing |
|
ANATOLİA TANI VE BİYOTEKNOLOJİ ÜRÜNLERİ ARAŞTIRMA GELİŞTİRME SANAYİ VE TİCARET A.Ş.
Designs, develops, and manufactures molecular diagnostic so…
|
ANGEN | TR | Manufacturing |
|
ANAVEX LIFE SCIENCES CORP.
Clinical-stage biopharmaceutical company developing therape…
|
AVXL | US | Manufacturing |
|
Anbio Biotechnology
Develops and provides in-vitro diagnostic (IVD) solutions a…
|
NNNN | KY | Manufacturing |
|
Anebulo Pharmaceuticals, Inc.
Clinical-stage biotech developing therapies for acute canna…
|
ANEB | US | Manufacturing |
|
AnGes, Inc.
Biopharmaceutical firm developing gene-based and nucleotide…
|
4563 | JP | Manufacturing |
|
ANG Lifesciences India Limited
Develops and manufactures sterile dry powder and liquid inj…
|
540694 | IN | Manufacturing |
|
ANHUI ANKE BIOTECHNOLOGY (GROUP)CO.,LTD.
Develops biopharmaceuticals, genetic engineering products, …
|
300009 | CN | Manufacturing |
Esperion Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32771/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32771 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32771 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32771 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32771}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Esperion Therapeutics, Inc. (id: 32771)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.